Latest Financials News

Energy Action Limited reported a 20.1% increase in revenue to $6.39 million for the half-year ended December 2025, driven by strong energy procurement growth. However, statutory profit after tax fell 35.7% to $593,881 amid rising expenses and amortisation.

Morphic Ethical Equities Fund Limited reported a half-year profit after tax of $1.26 million for December 2025, declaring a fully franked 1 cent dividend and continuing its share buy-back program.

BPH Energy Ltd reported a half-year net loss of $925,691, weighed down by investment write-downs and associate losses, while raising $1.2 million to fund exploration and development. The company’s future hinges on a Federal Court review of a critical offshore permit held by investee Advent Energy.

Carnavale Resources has retracted and replaced its recent investor presentation to correct overstated financial forecasts for gold prices above AUD 6,500/oz, reaffirming robust economics for its Kookynie Gold Project.

Cycliq Group Limited reported a 27% revenue decline for the half-year ending December 2025 but managed to return to profitability amid strategic platform upgrades and steady customer engagement.

Horizon Minerals unveils robust scoping study results for its Black Swan Project in WA, outlining a low-capital, high-return gold development targeting 102,000 ounces annually. The company launches a $175 million placement to fund construction and advance operations toward mid-2027 commissioning.

Stavely Minerals has locked in a $500,000 unsecured director loan facility to fund its 2026 Scoping Study targeting copper, gold, and silver production. This non-dilutive funding move underscores confidence from within the board as the company advances key projects.

Cauldron Energy has announced a major uranium resource upgrade at its Yanrey Project in Western Australia, now exceeding 55 million pounds of uranium oxide. Backed by strong project economics and fully funded drilling for 2026, the company is poised to capitalise on the global nuclear resurgence amid ongoing policy challenges.

Nexalis Therapeutics has completed a key capital raising milestone, issuing new shares, options, and performance rights following shareholder approval. This move supports the company’s clinical-stage drug development programs targeting pain and mental health.

Kali Metals Limited has successfully raised approximately A$7 million through a Tranche 1 Placement, issuing over 38 million new shares at 18 cents each. This capital injection marks a significant step in the company’s funding strategy.

Viva Leisure has announced a year-long on-market share buy-back program targeting up to 10% of its issued shares, aiming to capitalise on market volatility and reinforce its strong cash flow outlook.

Elementos Limited has raised $29.5 million through a strategic placement to L1 Capital, strengthening its financial position as it pushes forward with key tin projects in Spain and Tasmania.